Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?

por Orhan, Esin, Velazquez, Carolina, Tabet, Imene, Sardet, Claude, Theillet, Charles
Publicado 2021

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection

por Velázquez, Carolina, Lastra, Enrique, Avila Cobos, Francisco, Abella, Luis, de la Cruz, Virginia, Hernando, Blanca Ascensión, Hernández, Lara, Martínez, Noemí, Infante, Mar, Durán, Mercedes
Publicado 2020

BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib

por Velazquez, Carolina, Orhan, Esin, Tabet, Imene, Fenou, Lise, Orsetti, Béatrice, Adélaïde, José, Guille, Arnaud, Thézénas, Simon, Crapez, Evelyne, Colombo, Pierre-Emmanuel, Chaffanet, Max, Birnbaum, Daniel, Sardet, Claude, Jacot, William, Theillet, Charles
Publicado 2023

Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer

por Velázquez, Carolina, K., De Leeneer, Esteban-Cardeñosa, Eva M., Avila Cobos, Francisco, Lastra, Enrique, Abella, Luis E., de la Cruz, Virginia, Lobatón, Carmen D., Claes, Kathleen B., Durán, Mercedes, Infante, Mar
Publicado 2020